Thyrocare Technologies Limited (THYROCARE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.238x

Based on the latest financial reports, Thyrocare Technologies Limited (THYROCARE) has a cash flow conversion efficiency ratio of 0.238x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.27 Billion ≈ $13.75 Million USD) by net assets (Rs5.34 Billion ≈ $57.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Thyrocare Technologies Limited (THYROCARE) market capitalisation for the company's overall valuation and market capitalisation.

Thyrocare Technologies Limited - Cash Flow Conversion Efficiency Trend (2011–2026)

This chart illustrates how Thyrocare Technologies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Thyrocare Technologies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Thyrocare Technologies Limited ranked by their cash flow conversion efficiency. Explore THYROCARE cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Whitestone REIT NYSE:WSR	0.008x
Biotest Aktiengesellschaft XETRA:BIO	-0.114x
NCR Voyix Corporation NYSE:VYX	0.052x
Science Environmental Protection Co. Ltd. A SHG:688480	N/A
Brookline Bancorp Inc NASDAQ:BRKL	0.027x
Allianz Malaysia Bhd KLSE:1163	0.024x
Malion New Materials Co Ltd SHE:300586	0.008x
Redcare Pharmacy NV F:RDC	-0.039x

Annual Cash Flow Conversion Efficiency for Thyrocare Technologies Limited (2011–2026)

The table below shows the annual cash flow conversion efficiency of Thyrocare Technologies Limited from 2011 to 2026. View THYROCARE live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs5.86 Billion ≈ $63.38 Million	Rs2.16 Billion ≈ $23.39 Million	0.369x	+5.54%
2025-03-31	Rs5.47 Billion ≈ $59.16 Million	Rs1.91 Billion ≈ $20.69 Million	0.350x	+10.08%
2024-03-31	Rs5.28 Billion ≈ $57.06 Million	Rs1.68 Billion ≈ $18.13 Million	0.318x	+31.50%
2023-03-31	Rs5.35 Billion ≈ $57.88 Million	Rs1.29 Billion ≈ $13.98 Million	0.242x	+12.18%
2022-03-31	Rs5.27 Billion ≈ $56.95 Million	Rs1.13 Billion ≈ $12.26 Million	0.215x	-20.69%
2021-03-31	Rs4.27 Billion ≈ $46.21 Million	Rs1.16 Billion ≈ $12.55 Million	0.272x	-40.60%
2020-03-31	Rs3.67 Billion ≈ $39.65 Million	Rs1.68 Billion ≈ $18.13 Million	0.457x	+98.31%
2019-03-31	Rs4.35 Billion ≈ $47.06 Million	Rs1.00 Billion ≈ $10.85 Million	0.231x	-4.52%
2018-03-31	Rs4.43 Billion ≈ $47.94 Million	Rs1.07 Billion ≈ $11.57 Million	0.241x	+9.81%
2017-03-31	Rs4.07 Billion ≈ $43.99 Million	Rs894.44 Million ≈ $9.67 Million	0.220x	+18.57%
2016-03-31	Rs3.66 Billion ≈ $39.54 Million	Rs678.01 Million ≈ $7.33 Million	0.185x	+67.15%
2015-03-31	Rs3.11 Billion ≈ $33.60 Million	Rs344.68 Million ≈ $3.73 Million	0.111x	-50.51%
2014-03-31	Rs2.06 Billion ≈ $22.31 Million	Rs462.39 Million ≈ $5.00 Million	0.224x	-21.84%
2013-03-31	Rs1.60 Billion ≈ $17.31 Million	Rs459.23 Million ≈ $4.97 Million	0.287x	-28.11%
2012-03-31	Rs1.02 Billion ≈ $11.08 Million	Rs408.87 Million ≈ $4.42 Million	0.399x	-16.85%
2011-03-31	Rs675.33 Million ≈ $7.30 Million	Rs324.07 Million ≈ $3.50 Million	0.480x	--

About Thyrocare Technologies Limited

NSE:THYROCARE India Diagnostics & Research

Market Cap

$975.70 Million

Rs90.22 Billion INR

Market Cap Rank

#9065 Global

#443 in India

Share Price

Rs566.85

Change (1 day)

+0.02%

52-Week Range

Rs349.55 - Rs1591.90

All Time High

Rs1591.90